TipRanks
Go Ultimate55% OFF

Theriva Biologics (SFY0) Income Statement

Theriva Biologics Income Statement

Last quarter (Q2 2026), Theriva Biologics's total revenue was $0.00. In Q2, Theriva Biologics's net income was $-3.22M. See Theriva Biologics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ -108.00K$ 0.00$ 0.00$ 0.00$ 0.00
$ 14.91M$ 26.35M$ 21.43M$ 21.58M$ 14.27M
Depreciation and Amortization$ 108.00K$ 137.00K$ 135.00K$ 85.00K$ 87.00K
$ -23.63M$ -19.29M$ -21.96M$ -19.20M$ -14.18M
$ -15.02M$ -26.35M$ -21.43M$ -21.58M$ -14.27M
$ -8.72M$ 693.00K$ 1.44M$ 471.00K$ 6.00K
$ -23.74M$ -25.65M$ -19.99M$ -21.11M$ -14.27M
$ -25.25M$ -25.65M$ -18.35M$ -19.68M$ -14.27M
Per Share Metrics
Basic EPS$ -2.08$ -19.03$ -28.49$ -32.66$ -1.90
Diluted EPS$ -2.08$ -19.03$ -28.48$ -32.66$ -1.90
Weighted Average Shares Outstanding12.14M1.35M644.00K613.09K12.19M
Weighted Average Shares Outstanding (Diluted)12.14M1.35M644.28K613.09K12.19M

Currency in USD

Theriva Biologics Earnings and Revenue History

-30M-20M-10M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin